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To find the correlation between total and differential leukocytes count and the 
presence of microalbuminuria in diabetic patients. The results show significant positive 
correlation between total leukocytes count and microalbuminuria in males and females also 
there is significant positive correlation between neutrophils count and microalbuminuria in 
males and females but there is no correlation with other types of leukocytes. 
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Diabetes mellitus produces 
inadequate blood glucose control and leads to 
acute and chronic complications (Koda-
Kimble & Carlisle, 1995). Acute complications 
include diabetic ketoacidosis and 
hyperosmolar non ketotic coma (Singh & 
Marshall, 1995). Chronic complications can 
involve the kidneys, eyes, nervous system, 
and cardiovascular system and can be 
classified as either macrovascular or 
microvascular (Koda-Kimble & Carlisle, 
1995). 
Peripheral white blood cell (WBC) 
count has been shown to be associated with 
insulin resistance, type 2 diabetes (Schmidt et 
al., 1999; Vozarova et al., 2002; Ford, 2002; 
Ohshita et al., 2004), coronary artery disease 
(CAD) (Kannel et al., 1992; Weijenberg et al., 
1996; Danesh et al., 1998; Ohshita et al., 2004), 
stroke (Kannel et al., 1992), and diabetes 
micro- and macrovascular complications 
(Cavalot et al., 2002). An association between 
leukocytes counts and CAD has been 
observed in prospective and retrospective 
cohort studies as well as in case control 
studies; this association persists after 
adjusting for multiple coronary heart disease 
(CHD) risk factors, including smoking 
(Madjid et al., 2004). 
Leukocytes can be activated by 
advanced glycation end products (Pertynska-
Marczewska et al., 2004), oxidative stress 
(Shurtz-Swirski et al., 2004), angiotensin II 
(Lee et al., 2004), and cytokines (Scherberich, 
2003) in a state of hyperglycemia. 
Experimental evidence links the progression 
of diabetic nephropathy to intrarenal 
inflammation and leukocytic cell infiltrates 
(Meyer, 2003; Schena & Gesualdo, 2005; Mora 
& Navarro, 2005; Tuttle, 2005; Galkina & Ley, 
2006). Renal tissue macrophages, T cells, and 
neutrophils produce various reactive oxygen 
species (ROS), proinflammatory cytokines, 
metalloproteinases, and growth factors, 




which modulate the local response and 
increase inflammation within the diabetic 
kidney (Galkina & Ley, 2006). 
Study in men have found that a 
higher number of eosinophils in the blood 
correlates with higher urine albumin—a 
critical early sign of diabetic kidney disease 
and the link between eosinophil count and 
albumin excretion rate was even stronger 
than for known risk factors like Hypertension 
and eosinophil count was unrelated to 
albumin excretion in diabetic women (Fukui 
et al., 2009). 
Infiltrated macrophages are found 
within renal diabetic tissues, and studies 
demonstrated that macrophage-derived 
products can induce further inflammation in 
the diabetic kidney (Bohle et al., 1991; Furuta 
et al., 1993; Sassy-Prigent et al., 2000; Chow et 
al., 2004) One study revealed that peripheral 
lymphocyte count were negatively associated 
with systolic blood pressure, serum uric acid 
levels and this may provide some clues into 
the role of peripheral lymphocytes in 
protection from diabetic nephropathy (Chung 
et al., 2005). The aim of this study is to find 
the correlation between total and differential 
leukocytes count and the presence of 
microalbuminuria in diabetic patients. 
 
MATERIALS AND METHODS 
This study was done in Al-Hussein 
general hospital in Karbala province. The 
collection of samples was conducted during 
the period from June to November/ 2009. The 
study was conducted on 51 patients from the 
diabetic clinic in the mentioned hospital and 
24 healthy subjects (10 males and 14 females) 
were taken as control (total persons 75). All 
patients were infected with type 2 diabetes 
from which 23 males and 28 females. The 
ages of patients and controls were ranges 
between 35—65 years old. 
The medical history of each patient 
was taken which include age, gender, and 
duration of disease, type of treatment, family 
history, and history of any other illness. 
Measurements of height and weight were 
done to calculate body mass index and 
expressed as Kg/m2, measurement of blood 
pressure also done before takes samples of 
blood and urine, Blood pressure was 
measured after 30 min. rest, and the 
measurement was performed by using 
Mercury sphygmomanometer. The patient 
was seated with the back supported and the 
upper arm bore without constrictive clothing. 
The legs should not be crossed. The arm was 
supported at heart level and the bladder of 
the cuff was encircled at least 80% of the arm 
circumference with the stethoscope at the 
elbow crease over the brachial artery.  
The mercury column was inflated at 
the above systolic pressure then deflated at 2 
to 3 mm/s and the first and last audible 
sounds were taken as systolic and diastolic 
blood pressure. The column was read to the 
nearest 2 mmHg (Pickering et al., 2005). 
Samples were collected in fasting status. 
Blood samples were collected from healthy 
control and diabetic patients by vein 
puncture using 5 ml disposable syringes. 
Blood was divided into two parts. First part: 3 
ml was put in the centrifuge tube and 
allowed to clot for 15 min then it was 
centrifuged for approximately 10 minutes at a 
relative centrifugal force (RCF) of 1000 xg to 
2000 xg and separated the serum in plain tube 
for biochemical tests (Varley et al., 1991). 
Second part: 2 ml was put in EDTA tube; the 
blood was mixed gently and then used for 
hematological tests. 
The first morning urine was collected 
in disposable containers from diabetic 
patients. Microalbuminuria was measured by 
using semi-quantitative dry immunochemical 
screening strips (MICRAL-TEST marker 
made in Germany). Serum glucose was 
estimated by enzymatic color test on basis of 
Trinder reaction and the glucose Kit was the 
Biocon marker made in Germany. HbA1c was 
measured by using quantitative colorimetric 
determination of glycohemoglobin in whole 
blood and the HbA1c Kit was the Stanbio 




marker made in USA. Serum glucose and 
HbA1c were measured by photoelectric 
colorimeter from design APEL, AP 101/ 
Japan. Total leukocytes count was done 
manually by using 1 in 2 dilution of blood 
was made by adding 20 µl of well-mixed 
blood to 0.38 ml of lysing fluid (2% (20 ml/l) 
glacial acetic acid colored pale violet with 
gention violet) in glass tube. Mixed well and 
waited for 2 minutes then read by using 
counting chamber from type Improved 
Neubaer Slid (Lewis et al., 2001). Differential 
count of leukocytes was made by using 
Leishman’s stain (The Leishman’s stain Kit is 




The statistical analysis of this study 
was made by using SPSS program (Version 
16.0) and the statistical processes used here 
were Means, Standard deviations, 
Independent sample T-Test, Correlation 
coefficient and Linear regression. 
 
RESULTS 
Table (1) shows the results of males 
group. The results show no significant 
increase in BMI and there is significant 
increase in systolic and diastolic blood 
pressure, fasting blood sugar, HbA1c and 
microalbuminuria in patients group as 
compared with control group. Also the 
results show no significant increase in total 
and differential leukocytes count in patients 
group as compared with control group. 
 




(Mean ± SD) 
Control group 
n=10 
(Mean ± SD) 
Parameter 
--- 48.13±8.13 46.8±9.38 Age (years) 
0.423 27.31±3.00 28.34±4.00 BMI (Kg/m2) 
0.003 126.96±13.03 112.0±9.19 Systolic BP (mmHg) 
0.005 82.17±8.77 72.6±9.19 Diastolic BP (mmHg) 
<0.001 10.61±3.93 4.5 ±0.66 Fasting blood sugar(mmol/l) 
<0.001 8.29±1.4 6.08±0.40 HbA1c (%) 
0.362 7.16  ± 1.69 6.62 ± 1.11 Total leukocytes count (X109/L) 
0.370 4.47±1.48 4.01 0.99± Neutrophils count(X109/L) 
0.154 0.014 ± 0.028 0.034 ± 0.037 Basophils count (X109/L) 
0.168 0.11±0.05 0.17±0.11 Eosinophils count (X109/L) 
0.544 2.36 ± 0.72 2.21 ± 0.61 Lymphocytes count (X109/L) 
0.563 0.21 ± 0.12 0.18 ± 0.08 Monocytes count (X109/L) 
0.001 33.91 ± 1.8 10.0 ± 1.76 Microalbuminuria (mg/L) 
The significant differences at P-value <0.05 
 
 





Table (2) shows the results of females 
group. The results show no significant 
increase in BMI between control and patients 
group but there is significant increase in 
systolic and diastolic blood pressure, fasting 
blood sugar, HbA1c and microalbuminuria in 
patients group as compared with control 
group. The results of comparison in total and 
differential leukocytes count show significant 
increase in total leukocytes count in patients 
group as compared with control group also 
found significant increase in lymphocytes 
and monocytes count as compared with 
control group. The results of correlation 
between total and differential leukocytes 
count show significant positive correlation 
between total leukocytes count and micro-
albuminuria in both sexes. Also found 
positive correlation between neutrophils 
count and microalbuminuria in both sexes 
but there is no significant correlation with 
other types of leukocytes as shown in table 
(3).
 




(Mean ± SD) 
Control group 
n=14 
(Mean ± SD) 
Parameter 
--- 52.07±8.46 50.0 ± 10.87 Age (years) 
0.402 29.07±5.04 27.71±4.56 BMI (Kg/m2) 
<0.001 136.25±19.84 114.29±10.89 Systolic BP (mmHg) 
<0.001 11.60±85.71 9.94±72.86 Diastolic BP (mmHg) 
<0.001 11.83±4.47 4.35 ±0.79 Fasting blood sugar(mmol/l) 
<0.001 9.10±2.07 5.57±0.60 HbA1c (%) 
0.030 8.04  ± 2.17 6.84 ± 1.27 Total leukocytes count (X109/L) 
0.440 4.95±1.86 4.53±1.18 Neutrophils count(X109/L) 
0.916 0.011 ± 0.026 0.011 ± 0.021 Basophils count (X109/L) 
0.039 2.60 ± 0.92 2.02 ± 0.62 Lymphocytes count (X109/L) 
0.002 0.28 ± 0.18 0.16 ± 0.08 Monocytes count (X109/L) 
<0.001 33.42 ± 2.35 13.99 ± 2.60 Microalbuminuria (mg/L) 
The significant differences at P-value <0.05 
 
In males group the positive linear 
regression between total leukocytes count 
and microalbuminuria (Figure 1) was 
according to the linear equation (Y=-
35.57+9.0X) at level P=0.001 and correlation 
coefficient r=0.63 and in females (figure 2) the 
positive linear regression was according to 
the linear equation (Y=-19.59+7.59X) at level 
P=<0.001 and correlation coefficient r=0.51. 
The positive linear regression between 
neutrophils count and microalbuminuria in 
males group (Figure 3) was according to the 
linear equation (Y=-21.88+11.36X) at level 
P<0.001 and correlation coefficient r=0.69 and 
in females group (Figure 4) was according to 
the linear equation (Y=0.23+8.32X) at P=0.01 
and correlation coefficient r=0.48. 
 





Table 3: The Pearson’s Correlation between total and differential Leukocytes count and 
Microalbuminuria in males and females groups 
Microalbuminuria in 
  
females group (n=28) 
Microalbuminuria in 
males group (n=23) Parameter 
P r P r 
0.006 0.51 0.001 0.63 Total leukocytes count 
0.010 0.48 <0.001 0.69 Neutrophils count
0.233 -0.233 0.994 0.002 Basophils count 
0.162 0.272 0.824 0.049 Eosinophil count 
0.305 0.201 0.828 0.048 Lymphocytes count 
0.233 0.233 0.693 -0.087 Monocytes count 





















Figure 1: The relationship between microalbuminuria (mg/L) and total leukocytes count 
(X109/L) in males group. 
 
DISCUSSION 
The results show no significant 
differences in total leukocytes count in males 
group (Table 1) as compared with control 
group, despite this the mean of total 
leukocytes count was high and near the 
upper limit of normal leukocytes count, but 
there is significant increase in total leukocytes 
count in females group (Table 2) and we 
found elevation in Lymphocytes and 
monocytes count in females patients as 
compared with control group. This is may be 









companied with diabetes because leukocytes 
is one of the markers of inflammation. This 
finding is consistent with the hypothesis that 
a chronic activation of the immune system 
may play a role in the pathogenesis of type 2 
diabetes (Vosarova et al., 2002) and other 
study revealed that low and high levels of 
leukocytes count were associated with an 
increased risk of diabetes in young workers 




















Figure 2: The relationship between micoalbuminuria (mg/L) and total leukocytes count 



















Figure 3: The relationship between neutrophils count (X109/L) and microalbuminuria (mg/L) 



































Figure 4: The relationship between neutrophils count (X109/L) and microalbuminuria (mg/L) 
in females group. 
 
The study revealed significant 
positive correlation between micro-
albuminuria and peripheral total leukocytes 
count in males (Figure 1) and females (Figure 
2) and between microalbuminuria and 
neutrophils count in males (Figure 3) and 
females (Figure 4) and there is no significant 
correlation between microalbuminuria and 
other types of WBCs (Table 3), this study was 
supported by other study that found the 
peripheral WBCs, monocytes and neutrophils 
count increased in patients with the 
advancement of diabetic nephropathy 
(Chung et al., 2005) and the elevation in WBC 
count, even within the normal range, is 
associated with both macro and 
microvascular complications in type 2 
diabetes by the relation between albuminuria 
and WBCs. Chronic inflammation, as 
indicated by a higher WBC count, may play a 
linkage role in the development of macro- 
and microvascular complications in diabetes 
(Tong et al., 2004). 
The mechanisms responsible for the 
increased total and differential leukocytes in 
diabetic patients may be related to plasma 
cortisol and the changing insulin levels in 
renal disease. Both factors are known to 
increase WBCs count by increasing 
neutrophil influx from marrow storage and 
decreasing efflux from the blood stream 
(Bjornson et al., 1985; Collier et al., 1990). In 
addition, cortisol and insulin may increase 
the WBC count by stimulating leptin 
secretion from adipocytes (Wabitsch et al., 
1996) and leptin might be involved in 
increased leukocyte counts (Gainsford et al., 
1996; Laharrague et al., 2000). Leptin has been 
reported to stimulate myeloid differentiation 
from human bone marrow CD34_progenitors 
(Laharrague et al., 2000) and can induce 
proliferation, differentiation, and functional 
activation of hemopoietic cells (Gainsford et 
al., 1996). 
The data in this study showed that 
leukocytes play an important role in the 
initiation and progression of renal disease, 
including inflammatory mechanisms 
independent of infection, causing proteolytic 









(Shanmugam et al., 2003). TNF-α (Tumor 
necrosis factor- α) is an inflammatory 
cytokine produced by neutrophils, 
macrophages and, importantly, adipocytes 
and studies have shown that TNF-α and 
inflammation in general can contribute to the 
pathogenesis of diabetic nephropathy 
(Schalkwijk & Stehouwer, 2005). Tumor 
necrosis factor has the widest variety of 
biological activities and effects that contribute 
to development of diabetic nephropathy. 
Importantly, though, it causes direct renal 
injury as a cytotoxin, as well as affecting 
apoptosis, glomerular hemodynamics, 
endothelial permeability, and cell-cell 
adhesion. It also seems to play an important 
part in the early hypertrophy and 
hyperfunction of diabetic nephropathy 
(DiPetrillo et al., 2003; DiPetrillo et al., 2004; 
Navarro-Gonzalez et al., 2008). 
 
CONCLUSION 
Elevation in leukocytes count despite 
in the normal range especially neutrophils 
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